SCHEMBL13733657

SCHEMBL13733657

Nc1onc(-c2cccc(F)c2)c1C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
POLB P06746 2/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
LMNA P02545 5/20 0.59
TSHR P16473 4/20 0.59
HTT P42858 2/20 0.59
NPSR1 Q6W5P4 2/20 0.59
ALDH1A1 P00352 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
MAPT P10636 5/20 0.53
THRB P10828 2/20 0.53
MAPK1 P28482 2/20 0.52
SCD O00767 1/20 0.51
ATM Q13315 1/20 0.51
TP53 P04637 1/20 0.49
GAA P10253 1/20 0.48
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13734667 0.94 LMNA (0.60) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL13732808 0.90 TSHR (0.52) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL13733416 0.89 POLB (0.59) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL13733364 0.86 LMNA (0.51) KMT2APOLBSMN1; SMN2LMNATSHR
SCHEMBL13732816 0.86 KMT2A (0.53) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL13732904 0.86 LMNA (0.49) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL13735688 0.85 TSHR (0.49) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL13733490 0.85 TSHR (0.64) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL13735880 0.85 RAB9A (0.55) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL13732334 0.85 LMNA (0.56) MEN1KMT2APOLBSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9132126-B2 Phenyl-isoxazole derivatives and preparation process thereof IL-YANG PHARM. CO., LTD. (KR) 2015-09-15 US claimed
EP-2699566-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF Il-Yang Pharm. Co., Ltd. (KR) 2014-02-26 EP claimed
US-20140031364-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2014-01-30 US claimed
WO-2012144752-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2012-10-26 WO claimed
EP-2699566-B1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM CO LTD (KR) 2017-02-22 EP disclosed
US-9132126-B2 Phenyl-isoxazole derivatives and preparation process thereof IL-YANG PHARM. CO., LTD. (KR) 2015-09-15 US disclosed
EP-2699566-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF Il-Yang Pharm. Co., Ltd. (KR) 2014-02-26 EP disclosed
US-20140031364-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2014-01-30 US disclosed
WO-2012144752-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2012-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031364-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF PIR, ALPL, PIGS MEN1 4678/4885KMT2A 1622/4885POLB 948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.